Skip to main content
OpenTrials

Clinical trial condition

Transthyrexin Amyloidosis Cardiomyopathy

Explore clinical trials studying Transthyrexin Amyloidosis Cardiomyopathy. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Transthyrexin Amyloidosis Cardiomyopathy trial results

Recruiting

A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

NCT06539208

Conditions
Transthyretin Amyloidosis Polyneuropathy, Transthyrexin Amyloidosis Cardiomyopathy
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • The Second Xiangya Hospital of Central South University Changsha, Hunan, China
  • The First Affiliated Hospital, School of Medicine, Zhejiang University Hanzhou, Zhejiang, China
View Trial Details

Related conditions